Interventional Neuroradiology Market Size, Trends and Growth Analysis by 2027

The worldwide market for interventional neuroradiology is projected to grow significantly, reaching approximately US$ 3,254.55 million by 2027, up from US$ 1,969.39 million in 2018. This growth trajectory indicates a compound annual growth rate (CAGR) of 5.9% from 2019 to 2027.

Several factors are driving the expansion of the interventional neuroradiology sector, including an aging global population, a rising preference for minimally invasive surgical techniques, and an increase in the incidence of cerebral aneurysms. Nevertheless, challenges such as the high costs associated with embolization coils and a shortage of qualified professionals may hinder market growth during the forecast period. Conversely, the ongoing clinical trials aimed at stroke treatment are expected to positively influence the development of the global interventional neuroradiology market in the near future. Neurological disorders encompass a wide range of conditions affecting the brain, spine, and associated nerves, with over 600 recognized diseases, including brain tumors, epilepsy, Parkinson's disease, and strokes, along with less common conditions like frontotemporal dementia. In recent years, there has been a notable increase in the prevalence of neurological disorders. For instance, a brain aneurysm ruptures approximately every 18 minutes, with an annual rupture rate in the United States estimated at 8 to 10 per 100,000 individuals. Consequently, the growing incidence of cerebral aneurysms is expected to significantly contribute to market growth throughout the forecast period.

The interventional neuroradiology market is categorized by product type into neurovascular embolization and coiling assist devices, along with their accessories. In 2018, the neurovascular embolization and coiling assist devices segment commanded the largest share of the market, accounting for 72.17%. This segment is anticipated to maintain its leading position by 2027, driven by an increase in the volume of interventional neurology procedures. Furthermore, this segment is projected to experience substantial growth during the period from 2018 to 2027.

When segmented by disease, the global interventional neuroradiology market includes categories such as cerebral aneurysms, intra-cranial tumors, acute strokes, and other neurological conditions. In 2018, the acute strokes segment represented the largest share of the market, holding 42.16%. This segment is expected to continue its dominance through 2027, primarily due to the rising incidence of acute strokes, which are often linked to risk factors such as diabetes and smoking. Additionally, this segment is forecasted to grow at a significant rate during the 2018 to 2027 period.

The report incorporates a variety of primary and secondary sources relevant to interventional neuroradiology, including reputable organizations such as the World Health Organization (WHO), the National Center for Biotechnology Information (NCBI), the Canada First Research Excellence Fund (CFREF), the All India Institute of Medical Sciences (AIIMS), the Food and Drug Administration (FDA), the Neurology Association of South Africa (NASA), and the Brazilian Institute of Neuroscience and Neurotechnology (BRAINN), among others.